The affordable medicine segment generated revenues of $ ... products, pamidronate, fortum, and potassium phosphate ready-to-use IV bag. Our 505(b)(2) injectable bortezomib for multiple myeloma ...

Bernstein downgraded Fortum (FOJCY) to Market Perform from Outperform on the basis of reduced risk-reward. Easily identify stocks' risks and opportunities. Discover stocks' market position with ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Duke clinicians and patients discuss how approaches such as talk, music, and art therapy can address psychosocial issues that cancer survivors often face. Beyond Cancer: Building Bridges Experts ...

Experts discuss how cancer treatment and survivorship can be made more equitable and affordable through advocacy, outreach, and effective communication tools. Beyond Cancer: Caring for Young ...

Regenerative medicine is the branch of medicine that develops methods to regrow, repair or replace damaged or diseased cells, organs or tissues. Regenerative medicine includes the generation and ...

Distrust over the track record of domestically produced medicine runs deep in China. Such concerns spiraled into public uproar last month over the alleged questionable quality of Chinese generic ...

Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials ...

The deal covers global rights to three brands – Zinnat (cefuroxime axetil), Zinacef (cefuroxime) and Fortum (ceftazidime) – which are sold in more than 100 markets around the world and had ...

and Fortum (ceftazidime). The big challenge is making sure these drugs are used in the best way, to conserve their efficacy as new therapies come through the pipeline, and big part of the Ares ...